Sort
16,300 grants matching “fatty liver disease”
Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction
$726,132John Blangero · University Of Texas Rio Grande Valley · R01 · FY2022 · MD
Molecular Biology of the Metastatic Phenotype
$725,886Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
$725,577Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2016 · DK
Human adipose tissue in control of sympathetic tone and metabolic rate
$725,409Silvia Corvera · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · DK
Human adipose tissue in control of sympathetic tone and metabolic rate
$725,409Silvia Corvera · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · DK
Identification of Novel Small Molecule AMPK Modulators
$725,387Dave Musso · Curl Bio, Llc · R44 · FY2016 · DK
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors
$725,290Michelle Van Name · Yale University · R01 · FY2025 · DK
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$724,972Ryan Eugene Temel · University Of Kentucky · R01 · FY2015 · HL
Molecular signatures for liver cancer diagnosis and treatment stratification
$724,589Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The effects of orange juice compared with sugar-sweetened beverage on risk factors and metabolic processes associated with the development of cardiovascular disease and type 2 diabetes
$724,139Kimber Lee Stanhope · University Of California At Davis · R01 · FY2022 · HL
Obesity Prevention Targets for Down Syndrome
$724,096Lisa Ann Daunhauer · Colorado State University · R01 · FY2022 · HD
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors
$723,984Michelle Van Name · Yale University · R01 · FY2023 · DK
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD
$723,934Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2021 · DK
Novel Small Molecule Therapeutics to Treat Obesity
$723,900Susan Medghalchi · Fasgen, Inc. · R44 · FY2009 · DK
Novel Small Molecule Therapeutics to Treat Obesity
$723,900Susan Medghalchi · Fasgen, Inc. · R44 · FY2010 · DK
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease
$723,542Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · HL
Molecular Biophysics of Mitochondrial Membranes
$723,520Yuriy Kirichok · University Of California, San Francisco · R35 · FY2021 · GM
Nuclear Receptor Functional Profiling in Metabolism and Disease
$723,430Ronald M. Evans · Baylor College Of Medicine · U19 · FY2007 · DK
Deep Phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 Human Knockouts and Population Based Studies
$722,788Daniel James Rader · University Of Pennsylvania · R01 · FY2020 · HL
Thyroid Hormone Receptors in Health and Disease
$722,498Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS
$722,151Arun J Sanyal · Virginia Commonwealth University · R01 · FY2015 · DK
Endocannabinoids and the Control Of Behavior and Cardiovascular Function
$721,507George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
Carotid plaque characteristics by MRI in AIM-HIGH
$721,445Xue-Qiao Zhao · University Of Washington · R01 · FY2008 · HL
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$721,178Ryan Eugene Temel · University Of Kentucky · R01 · FY2017 · HL
Development of P2Y Receptor Ligands
$721,055Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK